Tonix Zeroes In On Fatigue As Go-Forward Endpoint In Long COVID

  
Tonix is developing the drug TNX-102 SL in long COVID • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip